Johnson & Johnson Financial Statements
Johnson & Johnson Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Johnson & Johnson Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 61,095.0 | 53,324.0 | 50,514.0 |
| Gross Profit ($ mil.) | 43,344.0 | 38,267.0 | 36,560.0 |
| Operating Income ($ mil.) | 13,661.0 | 13,150.0 | 13,223.0 |
| Total Net Income ($ mil.) | 10,576.0 | 11,053.0 | 10,411.0 |
| Diluted EPS (Net Income) | 3.63 | 3.73 | 3.46 |
Johnson & Johnson Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 16,450.0 | 16,194.0 | 15,957.0 |
| Gross Profit ($ mil.) | 11,699.0 | 11,580.0 | 11,223.0 |
| Operating Income ($ mil.) | 4,256.0 | 4,745.0 | 3,174.0 |
| Total Net Income ($ mil.) | 3,327.0 | 3,598.0 | 2,374.0 |
| Diluted EPS (Net Income) | 1.17 | 1.26 | 0.82 |
Johnson & Johnson Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.84 | 2.54 | 1.18 |
| Price/Earnings Ratio | 15.47 | 11.32 | 12.25 |
| Price/Book Ratio | 3.88 | 1.98 | 1.11 |
| Price/Cash Flow Ratio | 12.35 | 10.07 | 7.28 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Johnson & Johnson Financial Ratios
Johnson & Johnson Competitive Intelligence
| Merck | Novartis | Procter & Gamble | |
|---|---|---|---|
| Annual Sales ($ mil.) | 24,197.7 | 38,947.0 | 83,503.0 |
| Employees | 59,800 | 98,200 | -- |
| Market Cap ($ mil.) | 64,359.9 | -- | 200,462.6 |
Competitive Landscape
